Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saar I Gill

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|July 7, 2024
Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients With Acute Myeloid LeukemiaYu Kang, Benedicte Lefebvre, Ingrid Marti Pamies, et al.
Blood|November 9, 2019
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cellsMarco Ruella, David M Barrett, Olga Shestova, et al.
Leukemia & Lymphoma|January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantationCraig W Freyer, Alison Carulli, Noelle V Frey, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
scDNA: Single Cell DNA analysis software toolkit for subclonality discovery and assessmentMichael Bowman, Shreeya Gounder, Varsha Singh, et al.
Science Translational Medicine|August 31, 2023
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapyNils Wellhausen, Ryan P O'Connell, Stefanie Lesch, et al.
Transplantation and Cellular Therapy|June 30, 2022
Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with MyelofibrosisCraig W Freyer, Daria V Babushok, Noelle V Frey, et al.
Transplantation and Cellular Therapy|January 23, 2025
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell TherapyLuke Maillie, Sunita D Nasta, Jakub Svoboda, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplantLindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|July 7, 2024
Symptomatic Heart Failure and Clonal Hematopoiesis-Related Mutations in Patients With Acute Myeloid LeukemiaYu Kang, Benedicte Lefebvre, Ingrid Marti Pamies, et al.
Blood|November 9, 2019
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cellsMarco Ruella, David M Barrett, Olga Shestova, et al.
Leukemia & Lymphoma|January 24, 2024
Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantationCraig W Freyer, Alison Carulli, Noelle V Frey, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
scDNA: Single Cell DNA analysis software toolkit for subclonality discovery and assessmentMichael Bowman, Shreeya Gounder, Varsha Singh, et al.
Science Translational Medicine|August 31, 2023
Epitope base editing CD45 in hematopoietic cells enables universal blood cancer immune therapyNils Wellhausen, Ryan P O'Connell, Stefanie Lesch, et al.
Transplantation and Cellular Therapy|June 30, 2022
Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with MyelofibrosisCraig W Freyer, Daria V Babushok, Noelle V Frey, et al.
Transplantation and Cellular Therapy|January 23, 2025
Prolonged Neurologic Symptoms Following Immune Effector Cell-Associated Neurotoxicity Syndrome in Patients With Large B-cell Lymphoma Treated With Chimeric Antigen Receptor-Modified T Cell TherapyLuke Maillie, Sunita D Nasta, Jakub Svoboda, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 21, 2023
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplantLindsey Chippendale, Craig W Freyer, Alison Carulli, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
An integrated enzymatic and computational pipeline for quantifying off-target base-editingAlexander G McFarland, Soon-Keat Ooi, Davin Tafuri, et al.
Transplantation and Cellular Therapy|August 2, 2021
Characterization of Pericarditis following Allogeneic Hematopoietic Cell TransplantationCraig W Freyer, Michael Fradley, David Madnick, et al.
Pageof 6